{
  "name" : "dacemirror.sci-hub.se_journal-article_d5b2bdf90afa1760a6a40514ab3845d6_gul2019.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "A Comprehensive Review of Magnetic Nanomaterials Modern Day Theranostics",
    "authors" : [ "Saima Gul", "Sher Bahadar Khan", "Inayat Ur Rehman", "Murad Ali Khan" ],
    "emails" : [ "gorikhan@kust.edu.pk" ],
    "sections" : [ {
      "heading" : null,
      "text" : "REVIEW published: 31 July 2019\ndoi: 10.3389/fmats.2019.00179\nFrontiers in Materials | www.frontiersin.org 1 July 2019 | Volume 6 | Article 179\nEdited by: Mario Guagliano,\nPolitecnico di Milano, Italy\nReviewed by: Walter Caseri,\nETH Zürich, Switzerland Jian Yang,\nWuyi University, China\n*Correspondence: M. I. Khan\ngorikhan@kust.edu.pk\nSpecialty section: This article was submitted to\nPolymeric and Composite Materials, a section of the journal\nFrontiers in Materials\nReceived: 12 February 2019 Accepted: 09 July 2019 Published: 31 July 2019\nCitation: Gul S, Khan SB, Rehman IU, Khan MA and Khan MI (2019) A Comprehensive Review of Magnetic\nNanomaterials Modern Day Theranostics. Front. Mater. 6:179.\ndoi: 10.3389/fmats.2019.00179\nA Comprehensive Review of Magnetic Nanomaterials Modern Day Theranostics Saima Gul 1, Sher Bahadar Khan 2, Inayat Ur Rehman 3, Murad Ali Khan 1 and M. I. Khan 1*\n1 Department of Chemistry, Kohat University of Science & Technology, Kohat, Pakistan,2 Center of Excellence for Advanced Materials Research (CEAMR), King Abdulaziz University, Jeddah, Saudi Arabia,3 Gandhara College of Pharmacy, Gandhara University Peshawar, Peshawar, Pakistan\nSubstances at nanoscale, commonly known as nanomaterials, have always grabbed the attention of researchers for hundreds of years. Among these different types of nanomaterials, magnetic nanomaterials have been the focusof considerable attention during the last two decades as evidenced by an unprecedentedincrease in the number of research papers focusing these materials. Iron oxide magnetic nanoparticles have occupied a vital position in imaging phenomena; as drug vehicles, controlled/sustained release phenomena and hyperthermia; atherosclerosis diagnosis; prostate cancer. In fact, these are wonderful theranostic agents with some under clinical trials for human use. In this review, we have attempted to highlight the advances taking place in the eld of magnetic nanoparticles as theranostic agents. Extensive progress has been made in the two most important parameters, namely, control over the size and shape which decide the importance of iron oxide magnetic nanoparticles by developing suitable procedures like precipitation, co-precipitation, thermal decomposition, hydrothermal synthesis, microemulsion synthesis and plant mediated synthesis. After using a suitable synthetic route, workers encounter the most daunting task linked with the materials at nanoscale i.e., the protection against corrosion. Only properly protected iron oxide magnetic nanoparticles can be further connected to different functional systems to make building blocks for application in catalysis, biology and medicines. Finally, theranostics which is a combined application of imaging and drug deliveryhas been discussed. With all the potential uses, toxicity of the of iron oxide magnetic nanoparticles has been discussed.\nKeywords: iron oxide magnetic nanoparticles, synthetic rou tes, drug delivery, imaging, theranostic, atherosclerosis\nINTRODUCTION\nScientists, and materials scientists particularly, have shown remarkable interest in the properties of magnetic materials on the nanometer scale, while life scintists are also bene ting from nanomagnets (Buzug, 2010). Iron oxide magnetic nanoparticles are quite di erent from other nanomaterials as the fundamental properties of magnets are de ne at the nanoscale and measurements can be made in the range of a micrometer to a few nanometers in size (Riaz et al., 2015; Monsalve et al., 2017). Iron oxide magnetic nanoparticles are one of the most promising\nsubstances in clinical diagnostic and therapeutic applications (theranostics) (Ho et al., 2011; Ahmed et al., 2012). Superparamagnetism displayed by iron oxide magnetic nanoparticles makes ferromagnets useful for application in biomedical sciences; brie y, when compared with other nanomaterials, these are usually coated with inorganic materials like silica, organic fatty acids phospholipids, and so on, and these can be directed to active site by controlling with external AC magnetic eld making these attractive for biomedical applications (Figure 1) (Li et al., 2013).\nRecently, substantial e orts have been made in the eld of iron oxide magnetic nanoparticles to develop and understand their behavior and for improving their applicability (Bansal et al., 2017). Control over the synthetic procedures including surface functionalization is imperative as it leads to theirunique properties, such as physicochemical, stability and biologicalfate. For application in pharmaceutical and biomedical purposes, iron oxide magnetic nanoparticles should possess smaller siz (50 160 nm) and high magnetization values (Mohammed et al., 2017). Surface coatings are meant to ensure stability and biocompatibility for speci c localization at the target site (Figure 2) (Kandasamy, 2017).\nNevertheless, the intrinsic instability is an inevitable problem related with these particles when stored over certain periodsof time; as these small particles tend to agglomerate and reduce the energy associated with high surface to volume ratio of the nanoparticles (KovÆr et al., 2017). Uncapped magnetic iron oxide nanoparticles are highly reactive and prone to easy oxidation under ambient conditions damaging in magnet behavior and dispersion (Yu et al., 2014). For these reasons, it is critical to devise strategies to achieve stability of the naked magnetic iron oxide nanoparticles and degradation in the course and after the synthetic procedures. One approach is to coat the magnetic nanoparticles with layers of organic or inorganic stabilizing agents; the major advantage of this strategy isthat the coating not only gives stability, but these can further be usd for functionalization depending on the anticipated application (TombÆcz et al., 2015). After surface functionalization, iron oxide magnetic nanoparticles are capable of use as catalysts and biomarkers etc. (Pang et al., 2016). The objective this review is to bring into focus the syntheses and wide-ranging applicationsf iron oxide magnetic nanoparticles.\nSYNTHESIS OF IRON OXIDE MAGNETIC NANOPARTICLES\nA huge number of research papers have appeared during the last several decades describing the synthesis of magnetic iron oxide nanoparticles with versatile compositions and phases.\nSynthetic routes are selected to control shape, stability and dispersion trends of iron oxide magnetic nanoparticles (Figure 3). Excellent quality iron oxide magnetic nanoparticle can be synthesized by adopting versatile synthetic approaches include thermal decomposition, co-precipitation, micelle formation, hydrothermal and laser pyrolysis techniques. It was di cult for us to compile all this literature and we have\nattempted to present each synthetic approach by giving a few examples along with the corresponding formation mechanism (Ali et al., 2016; Martínez-Cabanas et al., 2016; Elrouby et al., 2017; Kandasamy, 2017; Lin et al., 2017; Liu et al., 2017; Rajiv et al., 2017; Sathya et al., 2017).\nSolution Precipitation To date, precipitation from homogeneous solutions is a classicl in use for decades for the lab-scale preparation of iron oxide magnetic nanoparticles (Pang et al., 2016). Routinely, during a precipitation reaction, a precipitating agent is added to the aqueous solution of metal precursor generating an insoluble solid product and the major bene t is the higher yields of the products. Another advantage of homogeneous precipitation reaction is the uniformity of the particles, a process that depends largely on the separation, the nucleation and growth of the particles (Yang et al., 2014).\nOverall, precipitation methods are simple and allow the preparation of magnetic iron oxide nanoparticles with rigorous size and shape control and these reactions are employed to obtain uniform size of the product. Nucleation must be avoided during the growth process for achieving the monodispersity of the iron oxide magnetic nanoparticles (Mahmed et al., 2011).\nCo-precipitation Methods Co-precipitation is perhaps a more suitable method to prepare magnetic iron oxide nanoparticles from aqueous solution containing Fe(II) and Fe(III) by adding a base under anaerobic condition at ambient or high temperatures (Lodhia et al., 2010). However, there are certain factors like the type of iron salts, Fe(II):Fe(III) ratio, temperature of the reaction, pH of the medium, volume and ionic strength of the solution that markedly a ect size, shape and composition of the magnetic iron oxide nanoparticles (Surowiec et al., 2017). In the co-precipitation approach, once the synthetic conditions are met, the quality of the magnetic iron oxide nanoparticles is successfully reproducible. At laboratory conditions, nanoscale magnetite tend to decompose easily to maghemite when dissolved in an acidic solution which is a ferrimagnetic material; therefore, magnetite can be deliberately oxidized to maghemite. This can be achieved by dispersing magnetite in acidic medium followed by the addition of Fe(III) nitrate; thus, the product obtained furnished excellent chemical stability to basic as well as acidic conditions. Therefore,alt ring conditions of the aforesaid process is the key in controllingthe dispersion behavior of magnetic iron oxide nanoparticles; the size and shape of the SPIONs can be successfully tailored by adjustment of pH, ionic strength, temperature, nature of the salts used and concentration ratio of FeII /FeIII . While addition of organic chelating agents or polymers surface complexing agents during the formation of magnetite can help to control the size of the nanoparticles (Mascolo et al., 2013).\nRecently, monodispersed magnetic iron oxide nanoparticles of variable sizes have been reported by the use of the stabilizing agent polyvinylalcohols in chainlike clusters signifying the importance of appropriate surfactant for stability (Freitas et al., 2015). Organic stabilizing agents containing carboxylate and hydroxide anions have been the priority choices as they\nFrontiers in Materials | www.frontiersin.org 2 July 2019 | Volume 6 | Article 179\nform surface complexes by competing mechanisms (Lu et al., 2007). First is the complex formation of metal ions which prevents nucleation; second is the adsorption of additives on nuclei thereby inhibiting particles’ growth (Boyer et al., 2010). All these facts make co-precipitation as the most widely used excellent synthetic route to obtain magnetic iron oxide nanoparticles.\nThermal Decomposition Approach In this approach, generally organometallics compounds are decomposed; organometallic precursors are decomposed in organic solvents using surfactants as capping agents under anaerobic conditions and it is a very diverse approach for the synthesis of magnetic iron oxide nanoparticles (Laurent et al., 2008). Thermal decomposition helps achieve control of the size and shape and dispersion behaviors of the nanomaterials; however, safety issues are associated at higher temperatures nd pressure of organic liquids and vapor phases used during the reactions conducted in the absence of air (Figure 4) (Dong et al., 2015). But one question has always arisen that, If the reaction is carried out in the absence of oxygen, how can metal oxide nanoparticles be formed successfully and reproducibly? The answer to this is example of iron oxide as in the rst step ferrous hydroxide is formed, which is then oxidized to\niron oxide by the protons of water to di erent types of iron oxides.\nReaction conditions, for instance temperature, duration of the reaction and the aging may also be vital for controlling size and morphology (Patsula et al., 2016). Annealing temperature is another factor which allows for the control of size and size distribution, namely the dispersion of the synthesized iron oxide magnetic nanoparticles, their structural motifs and magnetic properties. Monodispersed iron oxide magnetic nanoparticles in the size range of 6 20 nm were reported prepared by the polymer-catalyzed decomposition of reaction of Fe(CO)5 (Smith and Wychick, 1980; Huber, 2005). Literature also reports very precise control of the size of iron oxide magnetic nanoparticles; this was successfully achieved by thermally decomposing larger concentrations of expensive and toxic precursors as well as surfactants in organic medium. Precursors containing zerovalent metal like Fe(CO)5, initially lead to metallic nanoparticles followed by oxidation yielded high quality monodisperse iron oxide magnetic nanoparticles (E enberger et al., 2017). In contrast, iron(III) acetylacetonate when treated under identical conditions decomposed to cationic metal centers (Hufschmid et al., 2015). Another drawback associated with this method is the solubility of magnetic nanoparticles in organic solvents; this restricts their usage in biology and medicine. Even surface\nFrontiers in Materials | www.frontiersin.org 3 July 2019 | Volume 6 | Article 179\nmodi cation has no signi cant impact on the solubility of nanoparticles which are generally only dissolved in non-polar solvents (Dong et al., 2015).\nPolyol Method Polyol method is a liquid-phase synthetic approach for magnetic iron oxide nanoparticles in multivalent alcohols under higher boiling conditions (Hufschmid et al., 2015). Ethylene glycol is the simplest representative of the polyol family and, based on this, polyols comprise of a series of glycols diethylene glycol, triethylene glycol, tetraethylene glycol up to polyethylene glycol (Figure 5) (Deshmukh and Niederberger, 2017). Polyethylene glycol is available in a wide range of molecular weights and the respective product may contain up to 100,000 ethylene groups; other examples of this family are propanediol, butanediol, pentanediol, glycerol, and pentaerythritol and certain\nFrontiers in Materials | www.frontiersin.org 4 July 2019 | Volume 6 | Article 179\ncarbohydrates. Polyol is a very promising approach to synthesize uniform magnetic iron oxide nanoparticles, having the potential use in magnetic resonance imaging. The reason for the success of the polyol method is that all these polyols are watercomparable and chelation; polyols instantaneously coordinate to the nuclei formed and this allow excellent control of particle size, dispersity and particle distribution. Post synthesis treatment for the removal of polyols can be achieved easily by repeated washing with simple water, coordination exchangers like carboxylates, amines etc. and thermal annealing (Watt et al., 2017). Particle size increases with the increasing precursor’s concentration and water; particle size can be limited to minium depending on the solubility of the product in the polyol. A bigger advantage of the polyol method is the production of highly crystalline oxide nanoparticles based on elevation of the temperature of reaction medium; this rules out any post-sintering treatment of the product (Yang et al., 2014). Apart from conventional heating, other sources like microwaves and ultrasonic waves have been successfully applied (H mery et al., 2017). The synthesis of metal oxides can be restricted by the reducing action of polyols yielding elemental metals, and it is also possible by adjusting the reaction temperature (Wee et al., 2017).\nMicroemulsion Synthesis When two immiscible solvents are mixed together, a thermodynamically stable isotropic dispersion is formed which is de ned as microemulsion with the presence of an interfacial layer of surfactant’s molecules (de Toledo et al., 2018). Surfactants molecules generally bearing hydrophilic heads soluble in water and hydrophobic tails soluble in oil phase form a monolayer at the interface of the two immiscible liquids (wateroil) (Williams et al., 2016). Surfactant is an amphiphilic molecule playing a role to lower the water-oil interfacial tension to give a transparent solution. Microemulsion technique has several advantages when compared with other synthetic strategies. For example, with the use of simple equipment, a great variety of nanomaterials can be synthesized with excellent control over size, shape and composition, desired crystalline structu e and high speci c surface area, simple synthetic conditions\nat ambient/near ambient temperatures and pressures (Zhao et al., 2016). Microemulsions of water-in-oil are formed when microdroplets (up to 50 nm) of water surrounded by a monolayer of surfactant molecules are dispersed in continuous hydrocarbon phase (Drozdov et al., 2016). If two identical water-in-oil microemulsions containing the desired reagents are mixed,the microdroplets formed will experience continuous collisions, coalesce and break again and again leading to the appearance of precipitate inside the micelles. After completion of the reaction, acetone or ethylalcohol are added for extracting the precipitate via ltration or by centrifugation.\nMicroemulsions are termed as nanoreactors to produce nanoparticles, mixed metal-iron oxide magnetic (MFe2O4, M: rst row transition metals) nanoparticles are one of the most interesting materials used for electronic applications (GutiØrrez et al., 2015). MnFe2O4 nanoparticles in the range 4 15 nm are successfully synthesized through water-toluene inverse mic lles with sodium dodecylbenzenesulfonate surfactant, aqueous solutions of Mn(NO3)2 and Fe(NO3)3 as starting precursors. The microemulsion method used for the magnetic nanoparticles yielded spheroids with a rectangular cross section or as tube (Hasany et al., 2013). A wide range of magnetic nanomaterials have been synthesized using the microemulsion method with good control and the sizes, as well as shapes, usually varied over a wider range. In the microemulsion technique, large quantities of solvents are used to produce considerable amounts of nanomaterial; based on this, it’s categorized as a very e cient procedure and relatively di cult to be applied at large scale (Figure 6) (Kumar et al., 2013; Williams et al., 2016).\nHydrothermal Route Hydrothermal or solvothermal route is one of the most successful methods to prepare magnetic nanoparticles and ultra ne powders (Malo de Molina et al., 2016). By using this technique, crystals of di erent materials have been grown atisfactorily. Generally, hydrothermal synthesis accompanies higher temperatures (125 250 C) at very high pressures (0.3 4 MPa) (Cai et al., 2013; Madadlou et al., 2014; Yelenich et al., 2015). Powdery iron oxide magnetic nanoparticles with 40 nm diameter have been reported using hydrothermal route (140 C)\nFrontiers in Materials | www.frontiersin.org 5 July 2019 | Volume 6 | Article 179\nand a saturation magnetization of 85.8 emu. g 1, which is far lower than that of the bulk iron oxide.\nPrecursors’ concentration controls the size and size distribution; however, the duration of the reaction had a ect d the average particle size more signi cantly; monodisperse particles were obtained at shorter reaction times (Guo et al., 2013). An increase in the precursors’ concentration with the rest of the variables kept constant lead to spherical particles (15.6 4 nm) (Naghibi et al., 2014). A major drawback of the hydrothermal route is the slowness of kinetics at any given temperature; but this problem can be addressed using microwaves which can increase the kinetics of crystallization. A reaction mixture containing ethylene glycol, iron(III) chloride, sodium acetate and polyethylene glycol sealed insi e a\nstainless-steel autoclave (Te on-lined) was and heated at200 C for 8 72 h, yielded monodisperse spheres in the range of 200 800 nm. The mechanism is not yet clear, and the multicomponent approach seemed to be powerful in directing the formation of the desired materials.\nBiological Synthesis The introduction of Green Chemistry in nanotechnology has grabbed a great deal of attention from workers around the globe (Maryanti et al., 2014). The green chemistry approach includes chemical manipulations with the aim to either decrease or eliminate toxic materials dumped into the environment (Tadic et al., 2014; Nassar et al., 2016). Biological synthesis of metallic nanomaterials by plants resources is\nFrontiers in Materials | www.frontiersin.org 6 July 2019 | Volume 6 | Article 179\ncurrently under development and one of the most researched areas under investigation. Plant-mediated syntheses of metallic nanomaterials is the most modern option for researchers, carried out by using various parts of plants including tissue, extracts, exudates and other parts of the living plants. Green methods that are environmentally-friendly, safe and non-toxic for the development of reliable and eco-friendly methods to produce nanomaterials are of great importance in biomedical applications.\nBiological resources including microbes, enzymes, fungi ad plant extracts have been utilized as eco-friendly alternates for the synthesis of nanoparticles (Shah et al., 2015; Dhal et al., 2017). In some papers, plants and/or their parts proved to be bene cial over the other biological processes like microbial or enzymatic resources by elaborating work to maintain microbial culture. Plants are green resources for the biological synthesis of nanoparticles containing reducing agents for instance citric acid, ascorbic acid, avones, crude enzymes like dehydrogenases, reductases and extracellular electron shuttles, which plays a key role in the biological synthesis of nanoparticles (Figure 7) (Bai et al., 2009; Makarov et al., 2014; Baranwal et al., 2016).\nCarob leaf extract has been successfully employed as a rapid, non-toxic, facile and green resource for preparation of iron oxide magnetic nanoparticles in a single step reaction using Fe(III): Fe(II) and sodium hydroxide solutions (Baxter-Plant et al., 2003). The reaction occurred at a relatively low temperature range in a single-vessel reaction with an average diameter of he monodispersed nanoparticles (4 8 nm) coated with carboxylic groups of respective amide-I and II chain of the proteins present in the extract (Rai et al., 2015).\nAs the biological synthesis of nanoparticles is a comparatively newer approach and is developing, these are certain disadvantages associated with it, for example, plants produce low quantities of secreted proteins which lead to a decreased rate of synthesis, creating the following implications: culturing microorganisms which takes more time; the prime objective of the synthesis of nanoparticles regarding control over size, shape and crystallinity is only achieved with di cultly; and most importantly is the dispersity of the nanoparticles, which are preferably monodispersed. Another disadvantage is that all the plants are not capable of being put to use for the synthesis of nanoparticles. The researchers are still working on the mechanisms of metal ion uptake and biological reduction by green approach.\nDRUG DELIVERY\nAbout 40 years ago, the concept of magnetic drug delivery was introduced as a very promising application of magnetic nanomaterials (Iravani, 2011). The concept of magnetic targeting starts with attaching drug molecules to magnetic nanomateri ls followed by the injection and guidance of these particles to a site of action under the in uence of localized magnetic eld-gradients and holding there at site till the completion of therapy and nal removal (Awwad et al., 2013). Literature reveals six types of magnetic materials, i.e., diamagnetic,\nparamagnetic, ferromagnetic, superparamagnetic, ferromagnetic and antiferromagnetic (Njagi et al., 2010). When the external eld is removed, paramagnetic substances lose magnetic momentum and superparamagnetic materials become non-magnetic, but if an external eld is placed, these develop a mean magnetic momentum. Magnetic nanoparticles can carry large doses of drugs to achieve high local concentration, avoiding toxic and other adverse side e ects arising due to high drug doses in other parts of the organism (Langer, 1990). In vivo studies proved that actual clinical trials are a challenging task due to size control, stability, biocompatibility and coating-layer for drug binding and other physiological parameters.\nThe objective of developing and/or improving drug delivery systems is to position medications to target parts of the subject’s body through a medium that can control the therapy’s administration by means of a physiological or chemical trigger (Mody et al., 2014). Polymeric microspheres, micelles and hydrogels proved to be e ective in enhancing drug target speci city, systemic drug toxicity lowering, improved treatment absorption rate and protection of pharmaceuticals against biochemical degradation (Bucak et al., 2012; Kharissova et al., 2013; Kharisov et al., 2014; Hola et al., 2015; Jiles, 2015; Anselmo and Mitragotri, 2017; Seeli and Prabaharan, 2017). In addition to these, biodegradable polymer and dendrimers based experimental drug delivery systems displayed exciting signs of promise (Figure 8).\nDendrimers, due to their size and structure, are suitable carriers and these can be easily processed to good biocompatibility and biodegradation, but these are poor coating materials magnetic nanoparticles (Yu et al., 2017). Suitable materials may be nanoparticles, emulsions, micelles and dendrimers etc.; a typical drug delivery process includes the loading of drugs in biocompatible carrier materials, transferred to bodies for cancer treatment. Biocompatibility, subcellular size and targeting action make nanoparticles excellent carrier materials and several nanosized materials have shown interesting potential for drug delivery; this potential stems from their intrinsic magnetic properties, such as room temperature superparamagnetism, magnetization and high magnetic susceptibility (Figure 9).\nSurface functionalization by chemical as well as biological means improve stability and biocompatibility of the magnetic nanoparticles. The most interesting aspect of magnetic nanoparticles in drug delivery is the controlled delivery of drugs to target site under external magnetic elds. Magnetic driving of drugs to the target area is based on the binding of drugs to ferro uid and desorption from the ferro uid after reaching the target site by external magnetic eld. Still, a lot of workis needed to be done, as successful drug delivery is a ected by di erent factors, for example pH, temperature, osmolality, and so on (Veiseh et al., 2010). The strength of the external applied magnetic eld may hamper the magnetic drug delivery process as living cells withstand to a certain extent. The responsive nature of the magnetic nanoparticles carriers to external magnetic elds is due to the presence of incorporated magnetic materials, for example magnetite and some other transition metals and mix-metals (Figure 10).\nFrontiers in Materials | www.frontiersin.org 7 July 2019 | Volume 6 | Article 179\nWhile designing a magnetic targeted drug delivery system, certain factors must be borne in mind like strength of the applied magnetic eld and geometry. There are some other factors like magnetic properties and particles size, magnetic eld strength, drug loading capacity, remoteness of the target site and blood ow rate. The aim of the magnetically targeted drug delivery system is to carry the drug to the site of action at a rate needed by the body during the treatment time (Funke and Szeri, 2017).\nIMAGING\nThe most advanced application of nanoscale materials toward human health is the application of iron oxide magnetic nanoparticles-based formulations as a contrasting agent in magnetic resonance imaging (Fish et al., 2017). The past 50 years have seen remarkable improvements in diagnostic imaging procedures; for example in tumor diagnoses, damaged tissues and neurological disorders. Among various diagnostic imaging\nFrontiers in Materials | www.frontiersin.org 8 July 2019 | Volume 6 | Article 179\ntechniques, Magnetic Resonance Imaging abbreviated as MRI is an established tool in biomedical applications; exhibit stronger contrast of tissues makes it a favorable diagnostic test in medicine. In other diagnostic techniques like X-ray, the contrast quality is hindered leading to the misdiagnosis of several medical conditions. Looking at the superior contrast properties of MRIs, developments are needed and are made possible using a special medium called contrast agent (Hyeon et al., 2016). Contrast agent consists of a metal-based core with an external coating of a biocompatible material; the contrast agent intensi es the contrast of images obtained from MRI for accurate diagnoses. MRI equipment exerts a strong magnetic eld within the CAs as well as other magnetic particles of biological signi cance respond (Hachani et al., 2016). MRI contrasting agents are classi ed into ve categories as: T1, T2/T 2, CEST,\n19F-based and hyperpolarized agents (T1 and T2 are relaxation rates) (Sood et al., 2017).\nT1 agents include paramagnetic GdIII or MnII complexes capable of enhancing the magnetic resonance water signal known as signal brightening. The bene ts of using T1 contrasting agents relies on the high versatility of the interesting contrast mechanism that is dependent on their structures and biological aspects; for example, the use of paramagnetic complexes to see the delivery as well as the drug release from liposomes (Xiao et al., 2016). However, these systems have got limited sensitivity based\non the local concentration. To tackle this problem, scientists proposed the use of nanoscale materials which will aggravate umerous contrasting unit’s necessary to detect a T1 contrast. T1/T 2 contrasting agents are mostly superparamagnetic iron oxide nanoparticles capable of shortening T1/T 2 of water protons than T1 signal; in fact, they darken the MRI due to signal loss. T1/T 2 show higher intrinsic sensitivity than T1 contrasting agents which make them highly helpful in cellular imaging; this signal loss is undesirable as in the case of intrinsically low signal locations such as the lungs, whiler2 is the relaxivity of the CA as a function of e ect of concentration of the solution on the relaxation rates re ects the (Figure 11). This can be explained by classical outer-sphere relaxation theory that, with the increase in particle size, the relaxavity ratio (r1/r2) increases while decrease in particle’s size lead to better T1-shortening (Taboada et al., 2007; Xiao et al., 2016).\nCEST (Chemical Exchange Saturation Transfer) is the future of MRI contrasting agents; the principal governing CEST imaging is that these agents generate MRI contrast signals through chemical exchange of saturated protons from donor (CEST) to acceptor (water) (Taboada et al., 2007; Xiao et al., 2016). Th uniqueness of using CEST agents is that the contrasting signal can be detected by irradiating with the characteristic NMR resonance of the donor. The19F nucleus is the most sensitive\nFrontiers in Materials | www.frontiersin.org 9 July 2019 | Volume 6 | Article 179\nFIGURE 11 | T2-weighted contrasts and r2 color maps for iron oxide nanoparticles of different sizes (Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents) [adapted and modi ed from Estelrich et al. (2015)and Xu et al. (2016)].\nspin after proton so needs no enrichment, bearing similar detection sensitivity to CEST. Fluorinated agents are preferr d over other media agents, due to possible correlation of signal to agent concentration (Bünzli, 2016). Hyper polarized agents are the most sensitive media contrasting agents using polarization techniques which dramatically increase the population di erenc between the spin energy levels. These have got limited use because of the signal loss over time.\nBefore extending our discussion about nanoscale magnetic materials as contrasting media, somein vivo considerations must be discussed like toxicity, size and shape, and charge. Iron oxide magnetic nanoparticles are regarded as harmless for in vivo applications; based on iron’s concentration inside the human body. Iron becomes toxic at a concentration level of 60 mg/kg; iron oxide magnetic nanoparticles have been used as contrasting agents for more than two decades in clinics are below 1 mg/kg. However, iron oxide magnetic nanoparticles have been reported to have adverse e ects on cell cultures based on the proposal that the internalization of nanoparticles alters thefate of the cells. Iron oxide magnetic nanoparticles consist of two components, namely magnetic core and organic coatings, and the role of the contribution of either of these is di cult to asses. Moreover, the toxicity of iron oxide magnetic nanoparticles is not dependent only on organic coating but cell type as well. Iron oxide magnetic nanoparticles can induce oxidative stress by disturbing oxidant/antioxidant balance.\nBased on the size, charge and shape, the potential toxicity of iron oxide magnetic nanoparticles has been closely related totwo factors, their size and charge, while less is reported about the relation to shape. Sizes between 10 and 100 nm have longer halflifes in the blood and are small enough to go through capillaries; these considerations are to be kept in mind while cancer imaging is under discussion relevant to size (Estelrich et al., 2015; Xu et al.,\nFrontiers in Materials | www.frontiersin.org 10 July 2019 | Volume 6 | Article 179\n2016). Organic polymers of molecular weights above 50 kDa has been found to have an e ective blood half-life of 6 h. Thein vivoe ect of shape on the toxic behavior of iron oxide magnetic nanoparticles is di cult to assess because of the di culty in the preparation of comparable samples of nanoparticles with di erent shapes (McMahon and Bulte, 2018).\nTHERANOSTICS\nTheranostic is the seamless integration of therapy and diagnosis into one step; it is perhaps one of the trend setters in modern day research. The pivotal idea behind theranostic is that nanoparticles are unique in nature, i.e., these are capable of imaging and treating a lesion simultaneously (Khandhar et al., 2017). A careful survey of the literature revealed it was 2006 when this term was coined for the rst time in scienti c literature; theranostics was described as Future nanotechnology developments will most likely include the capability of designin and fabricating multifunctional nanoparticles to combine imaging and therapeutic capabilities ( theranostics ) (Sun et al., 2016). In this regard, iron oxide magnetic nanoparticles have attracted interest due to their unique magnetic properties which make these excellent MRI contrasting agents and e ective cytotoxic agents against tumors.\nThe use of nanoparticles allows imaging and treatment to be achieved simultaneously, in addition it also assists multiple treatment modalities in combination. This multi-modal approach was observed during the use of cisplatin-bonded gold nanospheres to administer chemo-radiotherapy in GBM cell models, leading to apoptic cell death after the intracellular uptake (Li et al., 2017). During the experiment, it was observed that due exposure to radiation in either of the metals started functioning as high atomic number radiosensitising agentsand initiated the release of photoelectrons and Auger electrons. Radiosensitisation of the nanoparticle’s formulations enha ced the in vitro cytotoxic e ects of chemo- and radiotherapy and contributed to the photoablation of tumor cells (Bissonnette and Bergeron, 2006). These results upstretched the prospect of concomitant administration of diagnostics and multiple forms of therapy.\nPhotoablation therapy is used for cancer treatment and is divided into two types, photothermal therapy (PTT) and photodynamic therapy (PDT) (Zheng et al., 2008). Among these, PTT is an excellent contender for cancer treatment and focuses on the use of photo-induced heat to kill cancer cells (Her et al., 2017). While in PDT treatment, a poorly soluble drug and visible light irradiations are used at certain wavelengths for generating reactive oxygen species such as singlet oxygen to kill cancer cells (McNamara and Tofail, 2017). PTT is an attractive method owing to advantages such as the safety of nontarget regions, its minimally invasive nature, fast recovery, and so on. Magnetic nanoparticles generate heat when placed in a varying magnetic eld due to magnetic hysteresis loss (Neelrelaxation and Brown-relaxation). This led scientists to apply these magnetic in hyperthermia treatment which is considere as a supplementary treatment to radiation, chemotherapy and\nurgery in cancer therapy (Marangon et al., 2017). Magnetic induction hyperthermia is based on the fact that when alternating magnetic eld is applied to magnetic nanoparticles, induced currents are generated and consequently heat is produced in magnetic nanoparticles. Based on this principal, when magnetic uids are exposed to alternating magnetic eld, the uids turn into powerful heat sources, destroying tumor cells, since these cells are more sensitive to temperatures more than 41 C than their normal counterparts (Gomer et al., 2016). PTT has certain disadvantages as well, like the need for high-power lasers and the thermal destruction of cancer selective cell lines. Recently, PDT has attracted considerable attention in cancer treatmen , as it is a non-invasive method, low energy light, site-speci c tumor targeting and negligible side e ects. Due to the poor solubility of drugs in water, these tend to accumulate in physiological media, hence indicating the need to work on developing improved drug delivery systems.\nPhotoacoustic imaging is a new method which is a combination of optical and acoustic imaging of burns, studying blood vessels, melanoma sites etc. This technique gives indepth analysis of various tissues, e.g., breast cancer cells, brain cancer cells and tumor monitoring (Sakellari et al., 2016). In photoacoustic tomography, the laser system used for photoacoustic imaging (532 nm) has great promise for non-invasive early diagnosis and the imaging of tumor cells and tissues. Gold nanoparticles have proven to be excellent non-invasive contrasting agents for early diagnosis of tumor by photoacoustic imaging. Computed tomography is one of the most common hospital’s diagnostic tools; it is another excellent imaging method for grabbing anatomical information. It is a choice made for clinical applications because of cost, e ciency, availability, deep tissue penetration and high spatial resolution. In this method, gold nanoparticles can be used as contrasting agents because of the high X-ray absorption, lower toxicity and slow clearance in the body. it was also suggested that gold nanoparticles may replace conventional iodine based contrasting agents as these reagents display renl toxicity and fast excretion. Gold nanoparticles displayed excellent biocompatibility, enhanced stability and increased accumulation in computed tomography tumor imaging (Kobayashi et al., 2016). Ultrasound imaging is a clinical diagnostic tool extensively used due to interesting features such as being non-invasive, cost-e ective and portable. Like all the other diagnostic imaging methods, contrasting agents can be adopted to enhance imaging precision in ultrasound imaging. In this method, microscale uorocarbon bubbles are typically used as contrasting agents: i literature, ultrasound imaging contrasting agents shouldfeature four characteristics, easy fabrication, easy administraton, high biosafety and excellent echogenicity.\nATHEROSCLEROSIS\nAtherosclerosis, a complex disease and one of the leading causes of death in the developed world (Chen et al., 2016). It is a chronic in ammation and remodeling processes which leads to the stenosis of the aorta; generally, it’s a gradual process spanning\nFrontiers in Materials | www.frontiersin.org 11 July 2019 | Volume 6 | Article 179\nover decades, but under certain conditions, it grows rapidly leading to an ischaemia.\nIn recent years, an extraordinary number of research projects have been funded to make advances in the diagnosis, prognosis and treatment of this fatal disease (Yildirim et al., 2016). Pathological detection of atherosclerosis has improved signi cantly with the use of magnetic resonance imaging due to contrasting agents and their excellent spatial resolution and average sensitivity; modern-day research in this area is probing new contrasting agents for improved imaging (FernÆndez-Ruiz, 2016). Other techniques used to detect early-stage atherosclerosis include computed tomography, photoacoustic tomography, positron emission tomography, single-photon emission computed tomography and uorescence molecular tomography and every technique has pluses as well as minuses. For example, some methods give outstanding sensitivity but low resolution while others have excellent resolution but lower sensitivity. Magnetic nanomaterials have shown the promise to implement magnetic nanomaterials binding to speci c surfaces to reduce the detection time (Brown et al., 2016).\nAs discussed earlier, iron oxide magnetic nanoparticles’ magnetic moments rotate rapidly when exposed to external magnetic eld and the magnetic ux gets enhanced; and upon the removal of the magnetic eld, Brownian motion causes randomization of the magnetic eld; this condition is superparamagentism which is observable only at nanoscale. Commonly used as good contrasting agents are gadoliniumbased substances; with adverse characteristics including cytotoxicity and the persistent accumulation of gadolinium. Iron oxide magnetic nanoparticles have better results as magnetic resonance imaging contrasting agents when compared with gadolinium and manganese oxide nanoparticles (Li et al., 2016). Gadolinium-based formulations are still dominating contrasting agents; however, after a careful survey of literature and recent clinical trials evidences, the future of iron oxide magnetic nanoparticles is highly promissory for diagnostic imaging guided therapy with the suitable incorporation of speci c ligands to well-de ned pathologies. So far, we have learnt that atherosclerosis may occur anywhere in the vascular system and the lack of sensitivity in the use of commercially available contrasting agents is a major challenge for the early diagnosis of the plaque which usually possesses a thickness and length. Positron emission tomography has low resolution for the detection of atherosclerotic plaque while the magnetic resonance imaging technique has excellent resolution but lacks sensitivity for pertinent screening. Superparamagnetic iron oxide nanoparticles synthesized by polyol method were successfully applied to mice as an MRI contrasting agent with promising results 5 h after post-injection treatment (Wang et al., 2016). More recently, thein vivo application of magnetic nanoparticles in the range of 90 nm allowed for excellent visuals of atherosclerotic plaque in mice; similarly, the NIRuorescence based method approach have also been applied\nwith interesting results (Cuadrado et al., 2016; Yoo et al., 2016; Schneider and Lassalle, 2017). In all three techniques, it was observed that the magnetic nanoparticles got accumulated inthe atherosclerotic area.\nCONCLUDING REMARKS\nMagnetic nanoparticles possess a great promise in drugdelivery systems due to their unique properties to overcome some of the problems to e ciently target diverse cell types. The future is encouraging as well as challenging and novel research ideas are needed to be worked out to prevent its limitations for the therapy of more diseases. Iron oxide magnetic nanoparticles possess a strong candidature for aqueous/nonaqueous phase solubility with great potential in medical applications. To achieve this, several factors play a key-role including suitable precursors, pH of the medium, coating agents and solvents for the synthesis of magnetic nanoparticles. Aqueous phase solubility can be signi cantly improved by using water-soluble surface functionalization agents via thermal decomposition, co-precipitation, microwave and high-temperature methods.\nMRI is a non-invasive imaging technique used to study anatomical site and biologically compatible nanomaterials aid in detailed images for more accurate diagnosis. Magnetic nanoparticles act as contrasting agents which are advantageous to improve the contrast in these images. Magnetic iron oxide nanoparticles have been the key focus in this review article; which are stabilized by increasing the hydrophilicity through coatings onto the metal surface followed by the attachment of additional ligands like antibodies etc. Nextis the speci c linking to signal-secreting cells which permits speci c agglomeration of nanoparticles to the in amed/tumor bearing site. Contrast is still a challenge in MRI and new improvements are being sought through labeled magnetic nanoparticles with a uorescent protein, such as green uorescent protein or red uorescent protein; giving rise to a distinct color of the target area under investigation. This research requires more intensein vivo studies which will lead to improve the biological compatibilities and any possible negative side e ects associated with the injection of magnetic nanoparticles. Magnetic iron oxide nanoparticles comparatively proved to be a highly reliable and better theranostic option as gadolinium complexes gives excellent contrast, but these are nephrotoxic.\nFinally, the scienti c information collected here while compiling this review opens novel insights into the role of magnetic nanoparticles to develop nanocarriers enabled to increase the e ciency of the modern-day theranostics.\nAUTHOR CONTRIBUTIONS\nSG compiled this review article with collective scholarly contribution of all the co-authors.\nFrontiers in Materials | www.frontiersin.org 12 July 2019 | Volume 6 | Article 179\nREFERENCES\nAhmed, N., Fessi, H., and Elaissari, A. (2012). Theranostic applications of nanoparticles in cancer.Drug Discovery Today17, 928 934. doi: 10.1016/j.drudis.2012.03.010 Ali, A., Hira Zafar, M. Z., ul Haq, I., Phull, A. R., Ali, J. S., and Hussain, A. (2016). Synthesis, characterization, applications, and challenges of iron oxide nanoparticles.Nanotechnol. Sci. Appl.9:49. doi: 10.2147/NSA.S99986 Anselmo, A. C., and Mitragotri, S. (2017). Impact of particle elasticity on particle-based drug delivery systems.Adv. Drug Delivery Rev.108, 51 67. doi: 10.1016/j.addr.2016.01.007 Awwad, A. M., Salem, N. M., and Abdeen, A. O. (2013). Green synthesis of silver nanoparticles using carob leaf extract and its antibacterial activity. Int. J. Ind. Chem.4:29. doi: 10.1186/2228-5547-4-29 Bai, H. J., Zhang, Z. M., Guo, Y., and Yang, G. E. (2009). Biosynthesis of cadmium sul de nanoparticles by photosynthetic bacteria Rhodopseudomonas palustris.Colloids Surfaces B Biointerfaces70, 142 146. doi: 10.1016/j.colsurfb.2008.12.025 Bansal, R., Nagórniewicz, B., Storm, G., and Prakash, J. (2017). Relaxincoated superparamagnetic iron-oxide nanoparticles as a novel theranostic approach for the diagnosis and treatment of liver brosis.J. Hepatol.66:S43. doi: 10.1016/S0168-8278(17)30348-3 Baranwal, A., Mahato, K., Srivastava, A., Maurya, P. K., and Chandra, P. (2016). Phytofabricated metallic nanoparticles and their clinical applications.RSC Adv. 6, 105996 106010. doi: 10.1039/c6ra23411a Barrow, M., Taylor, A., Murray, P., Rosseinsky, M. J., and Adams, D.J. (2015). Design considerations for the synthesis of polymer coated iron oxide nanoparticles for stem cell labelling and tracking using MRI.Chem. Soc. Rev. 44, 6733 6748. doi: 10.1039/c5cs00331h Baxter-Plant, V. S., Mikheenko, I. P., and Macaskie, L. E. (2003). Sulphate-reducing bacteria, palladium and the reductive dehalogenation of chlorinated romatic compounds.Biodegradation14, 83 90. doi: 10.1023/A:1024084611555 Bissonnette, L., and Bergeron, M. G. (2006). Next revolution inthe molecular theranostics of infectious diseases: microfabricated systems for personalized medicine. Expert Rev. Mol. Diagnost.6, 433 450. doi: 10.1586/14737159. 6.3.433 Boyer, C., Whittaker, M. R., Bulmus, V., Liu, J., and Davis, T. P. (2010). The design and utility of polymer-stabilized iron-oxide nanoparticles for nanomedicine applications.NPG Asia Mater.2:23. doi: 10.1038/asiamat.2010.6 Brown, A. J., Teng, Z., Evans, P. C., Gillard, J. H., Samady, H., and Bennett, M. R. (2016). Role of biomechanical forces in the natural historyof coronary atherosclerosis.Nat. Rev. Cardiol.13:210. doi: 10.1038/nrcardio.2015.203 Bucak, S., Yavuztürk, B., and Sezer, A. D. (2012). Magnetic nanoparticles: synthesis, surface modi cations and application in drug delivery, in Recent Advances in Novel Drug Carrier Systems(IntechOpen). Available online at: https://www.cd-bioparticles.com/t/Drug-Delivery_51.html (access d October 22, 2017). Bünzli, J. C. G. (2016). Lanthanide light for biology and medicaldiagnosis.J. Luminescence170, 866 878. doi: 10.1016/j.jlumin.2015.07.033 Buzug, T. M. (2010). Magnetic nanoparticles: particle science, imag ng technology, and clinical applications, inProceedings of the First International Workshop on Magnetic Particle Imaging. Singapore: World Scienti c. Cai, H., An, X., Cui, J., Li, J., Wen, S., Li, K., et al. (2013). Facile hydrothermal synthesis and surface functionalization of polyethyleneimine-coated iron oxide nanoparticles for biomedical applications.ACS Appl. Mater. Interfaces5, 1722 1731. doi: 10.1021/am302883m Chen, Y., Ma, M., Chen, H., and Shi, J. (2016). Multifunctional hollow mesoporous silica nanoparticles for MR/US imaging-guided tumor therapy, in Advances in Nanotheranostics II, ed Z. Dai (Singapore: Springer), 189 222. doi: 10.1007/978-981-10-0063-8_6 Cuadrado, I., Saura, M., Castejón, B., Martin, A. M., Herruzo, I., Balatsos, N., et al. (2016). Preclinical models of atherosclerosis. The future of Hybrid PET/MR technology for the early detection of vulnerable plaque.Expert Rev. Mol. Med. 18:e6. doi: 10.1017/erm.2016.5 de Toledo, L. D. A. S., Rosseto, H. C., and Bruschi, M. L. (2018). Iron oxide magnetic nanoparticles as antimicrobials for therapeutics.Pharmaceut. Dev. Technol.23, 316 323. doi: 10.1080/10837450.2017.1337793\nDeshmukh, R., and Niederberger, M. (2017). Mechanistic aspect in the formation, growth and surface functionalization of metal oxide nanoparticles in organic solvents.Chem. Eur. J.23, 8542 8570. doi: 10.1002/chem.201605957 Dhal, S., Mohanty, A., Yadav, I., Uvanesh, K., Kulanthaivel, S., Banerjee, I., et al. (2017). Magnetic nanoparticle incorporated oleogel as iontophoretic drug delivery system.Colloids Surfaces B Biointerfaces157, 118 129. doi: 10.1016/j.colsurfb.2017.05.061 Dong, H., Chen, Y. C., and Feldmann, C. (2015). Polyol synthesis of nanoparticles: status and options regarding metals, oxides, chalcogenides, and no -metal elements.Green Chem.17, 4107 4132. doi: 10.1039/C5GC00943J Drozdov, A. S., Ivanovski, V., Avnir, D., and Vinogradov, V. V.(2016). A universal magnetic ferro uid: nanomagnetite stable hydrosol with no added dispersants and at neutral pH.J. Colloid Interface Sci.468, 307 312. doi: 10.1016/j.jcis.2016.01.061 E enberger, F. B., Couto, R. A., Kiyohara, P. K., Machado, G.,Masunaga, S. H., Jardim, R. F., et al. (2017). Economically attractive route for the preparation of high quality magnetic nanoparticles by the thermal decomposition of iron (III) acetylacetonate.Nanotechnology28:115603. doi: 10.1088/1361-6528/aa5ab0 Elrouby, M., Abdel-Mawgoud, A. M., and El-Rahman, R. A. (2017). Synthesis of iron oxides nanoparticles with very high saturation magnetizationf rm TEAFe (III) complex via electrochemical deposition for supercapacitor applications. J. Mol. Struct.1147, 84 95. doi: 10.1016/j.molstruc.2017.06.092 Estelrich, J., SÆnchez-Martín, M. J., and Busquets, M. A. (2015). Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents.I t. J. Nanomed.10:1727. doi: 10.2147/ijn.s76501 FernÆndez-Ruiz, I. (2016). Immune system and cardiovascular dise se.Nat. Rev. Cardiol.13:503. doi: 10.1038/nrcardio.2016.127 Fish, M. B., Fromen, C. A., Lopez-Cazares, G., Golinski, A. W., Scott, T. F., Adili, R., et al. (2017). Exploring deformable particles in vascular-targeted drug delivery: softer is only sometimes better.Biomaterials124, 169 179. doi: 10.1016/j.biomaterials.2017.02.002 Freitas, J. C. D., Branco, R. M., Lisboa, I. G. O., Costa, T. P. D., Campos, M. G. N., Jafelicci Jœnior, M., et al. (2015). Magnetic nanoparticles obtained by homogeneous coprecipitation sonochemically assisted.Mater. Res.18, 220 224. doi: 10.1590/1516-1439.366114 Funke, C., and Szeri, A. J. (eds.). (2017). Osmolarity as a contributing factor in topical drug delivery, inAPS Division of Fluid Dynamics Meeting Abstracts (Vancouver, BC). Gomer, C. J., Luna, M., Ferrario, A., Rucker, N., and Wong, S. (2016). The tumor microenvironment modulates responsiveness to photodynamic therapy, in Photodynamic Medicine: From Bench to Clinic, eds H. Kostron and T. Hasan (The Royal Society of Chemistry), 87 99. doi: 10.1039/9781782626824-00087 Guo, Y., Wang, Z., Shao, H., and Jiang, X. (2013). Hydrothermal synthesis of highly uorescent carbon nanoparticles from sodium citrate and their use for the detection of mercury ions.Carbon 52, 583 589. doi: 10.1016/j.carbon.2012.10.028 GutiØrrez, L., Costo, R., Grüttner, C., Westphal, F., Gehrke, N., Heinke, D., et al. (2015). Synthesis methods to prepare single-and multi-core iron oxide nanoparticles for biomedical applications.Dalton Transac.44, 2943 2952. doi: 10.1039/C.4D.T.03013C Habibi, N., Pastorino, L., Babolmorad, G., Ruggiero, C., Guda, T., and Ong, J. L. (2017). Polyelectrolyte multilayers and capsules: S-layer functionalization for improving stability and biocompatibility.J. Drug Delivery Sci. Technol.38, 1 8. doi: 10.1039/C5CS00331H Hachani, R., Lowdell, M., Birchall, M., Hervault, A., Mertz, D., Begin-Colin, S., et al. (2016). Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents. Nanoscale 8, 3278 3287. doi: 10.1039/C5NR 03867G Hasany, S., Abdurahman, N., Sunarti, A., and Jose, R. (2013). Magnetic iron oxide nanoparticles: chemical synthesis and applications review.Curr. Nanosci.9, 561 575. doi: 10.2174/15734137113099990085 Hemery, G., Keyes A. C. Jr., Garaio, E., Rodrigo, I., Garcia, J. A., Plazaola, F., et al. (2017). Tuning sizes, morphologies, and magnetic propertiesof monocore versus multicore iron oxide nanoparticles through the controlled addition of water in the polyol synthesis.Inorg. Chem.56, 8232 8243. doi: 10.1021/acs.inorgchem.7b00956\nFrontiers in Materials | www.frontiersin.org 13 July 2019 | Volume 6 | Article 179\nHer, S., Ja ray, D. A., and Allen, C. (2017). Gold nanoparticles for applications in cancer radiotherapy: mechanisms and recent advancements.Adv. Drug Delivery Rev.109, 84 101. doi: 10.1016/j.addr.2015.12.012 Ho, D., Sun, X., and Sun, S. (2011). Monodisperse magnetic nanoparticles for theranostic applications. Accounts Chem. Res.44, 875 882. doi: 10.1021/ar200090c Hola, K., Markova, Z., Zoppellaro, G., Tucek, J., and Zboril, R. (2015). Tailored functionalization of iron oxide nanoparticles for MRI, drug delivery, magnetic separation and immobilization of biosubstances.Biotechnol. Adv.33, 1162 1176. doi: 10.1016/j.biotechadv.2015.02.003 Huber, D. L. (2005). Synthesis, properties, and applications of iron nanoparticles. Small1, 482 501. doi: 10.1002/smll.200500006 Hufschmid, R., Arami, H., Ferguson, R. M., Gonzales, M., Teeman, E., Brush, L. N., et al. (2015). Synthesis of phase-pure and monodisperse iron oxide nanoparticles by thermal decomposition.Nanoscale7, 11142 11154. doi: 10.1039/C5NR01651G Hyeon, T., Piao, Y., and Park, Y. I. (2016).U.S. Patent No. 9,352,058. Washington, DC: U.S. Patent and Trademark O ce. Iravani, S. (2011). Green synthesis of metal nanoparticles using plants. Green Chem.13, 2638 2650. doi: 10.1039/c1gc15386b Jiles, D. (2015).Introduction to Magnetism and Magnetic Materials. Boca Raton, FL: CRC Press. Kandasamy, R. (2017). A novel single step synthesis and surface fun tionalization of iron oxide magnetic nanoparticles and thereof for the copper removal from pigment industry e uent. Separation Puri cation Technol.188, 458 467. doi: 10.1016/j.seppur.2017.07.059 Khandhar, A. P., Keselman, P., Kemp, S. J., Ferguson, R. M., Goodwill, P. W., Conolly, S. M., et al. (2017). Evaluation of PEG-coated iron oxidenanoparticles as blood pool tracers for preclinical magnetic particle imaging.Nanoscale9, 1299 1306. doi: 10.1039/C6NR08468K Kharisov, B. I., Dias, H. R., Kharissova, O. V., VÆzquez, A., Pena Y., and Gomez, I. (2014). Solubilization, dispersion and stabilization of magnetic nanoparticles in water and non-aqueous solvents: recent trends.RSC Adv.4, 45354 45381. doi: 10.1039/c4ra06902a Kharissova, O. V., Dias, H. R., Kharisov, B. I., PØrez, B. O., and PØrez, V. M. J. (2013). The greener synthesis of nanoparticles.Trends Biotechnol.31, 240 248. doi: 10.1016/j.tibtech.2013.01.003 Kobayashi, T., Ito, A., and Honda, H. (2016). Magnetic nanoparticlemediated hyperthermia and induction of anti-tumor immune responses, in Hyperthermic Oncology from Bench to Bedside, eds S. Kokura, T. Yoshikawa, and T. Ohnishi (Singapore: Springer), 137 150. doi: 10.1007/978-981-10-0719-4_13 KovÆr, D., MalÆ, A., Ml cochovÆ, J., Kalina, M., FohlerovÆ, Z., HlavÆ cek, A., et al. (2017). Preparation and characterisation of highly stable ironoxide nanoparticles for magnetic resonance imaging.J. Nanomater.2017:7859289. doi: 10.1155/2017/7859289 Kumar, A., Saxena, A., De, A., Shankar, R., and Mozumdar, S. (2013). Facile synthesis of size-tunable copper and copper oxide nanoparticles using reverse microemulsions.Rsc Adv.3, 5015 5021. doi: 10.1039/c3ra23455j Langer, R. (1990). New methods of drug delivery.Science249, 1527 1533. doi: 10.1126/science.2218494 Laurent, S., Forge, D., Port, M., Roch, A., Robic, C., Vander Elst, L., et al. (2008). Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications.Chem. Rev.108, 2064 2110. doi: 10.1021/cr068445e Li, J., Wang, S., Shi, X., and Shen, M. (2017). Aqueous-phase synth is of iron oxide nanoparticles and composites for cancer diagnosis and therapy.Adv. Colloid Interface Sci.249, 374 385. doi: 10.1016/j.cis.2017.02.009 Li, L., Jiang, W., Luo, K., Song, H., Lan, F., Wu, Y., et al. (2013). Superparamagnetic iron oxide nanoparticles as MRI contrast agents for non-invasivetem cell labeling and tracking.Theranostics3:595. doi: 10.7150/thno.5366 Li, X., Wang, C., Tan, H., Cheng, L., Liu, G., Yang, Y., et al. (2016). Gold nanoparticles-based SPECT/CT imaging probe targeting for vulnerable atherosclerosis plaques.Biomaterials 108, 71 80. doi: 10.1016/j.biomaterials.2016.08.048 Lin, L., Starostin, S. A., Hessel, V., and Wang, Q. (2017). Synthesis of iron oxide nanoparticles in microplasma under atmospheric pressure.Chem. Eng. Sci.168, 360 371. doi: 10.1016/j.ces.2017.05.008 Liu, Y., Yang, J., Xie, M., Xu, J., Li, Y., Shen, H., et al. (2017). Synthesis of polyethyleneimine-modi ed magnetic iron oxide nanoparticles without adding base and other additives.Mater. Lett. 193, 122 125. doi: 10.1016/j.matlet.2017.01.056 Lodhia, J., Mandarano, G., Ferris, N. J., Eu, P., and Cowell, S. F. (2010). Development and use of iron oxide nanoparticles (Part 1): synthesis of iron oxide nanoparticles for MRI.Biomed. Imag. Intervent. J.6:e12. doi: 10.2349/biij.6.2.e12 Lu, A. H., Salabas, E. L., and Schüth, F. (2007). Magnetic nanoparticles: synthesis, protection, functionalization, and application.Angew. Chem. Int. Ed.46, 1222 1244. doi: 10.1002/anie.200602866 Madadlou, A., Jaberipour, S., and Eskandari, M. H. (2014). Nanoparticula ion of enzymatically cross-linked whey proteins to encapsulate ca eine via microemulsi cation/heat gelation procedure.LWT-Food Sci. Technol.57, 725 730. doi: 10.1016/j.lwt.2014.02.041 Mahmed, N., Heczko, O., Söderberg, O., and Hannula, S. P. (2011). Room temperature synthesis of magnetite (Fe3O4) nanoparticles by a simple reverse co-precipitation method, in IOP Conference Series: Materials Science and Engineering(Bristol: IOP Publishing). doi: 10.1088/1757-899X/18/3/032020 Makarov, V. V., Makarova, S. S., Love, A. J., Sinitsyna, O. V., Dudnik, A. O., Yaminsky, I. V., et al. (2014). Biosynthesis of stable iron oxidenanoparticles in aqueous extracts ofHordeum vulgareand Rumex acetosaplants.Langmuir 30, 5982 5988. doi: 10.1021/la5011924 Malo de Molina, P., Zhang, M., Bayles, A. V., and Helgeson, M. E. (2016). Oil-inwater-in-oil multinanoemulsions for templating complex nanoparticles.Nano Lett.16, 7325 7332. doi: 10.1021/acs.nanolett.6b02073 Marangon, I., Silva, A. A., Guilbert, T., Kolosnjaj-Tabi, J., Marchiol, C., and Natkhunarajah, S. (2017). Tumor sti ening, a key determinant oftumor progression, is reversed by nanomaterial-induced photothermal therapy. Theranostics7:329. doi: 10.7150/thno.17574 Martínez-Cabanas, M., López-García, M., Barriada, J. L., Herrero, R., and de Vicente, M. E. S. (2016). Green synthesis of iron oxide nanoparticles. Development of magnetic hybrid materials for e cient As(V) removal.Chem. Eng. J.301, 83 91. doi: 10.1016/j.cej.2016.04.149 Maryanti, E., Damayanti, D., and Gustian, I. (2014). Synthesis of ZnO nanoparticles by hydrothermal method in aqueous rinds extracts of Sapindus rarak DC.Mater. Lett.118, 96 98. doi: 10.1016/j.matlet.2013.12.044 Mascolo, M., Pei, Y., and Ring, T. (2013). Room temperature co-precipitation synthesis of magnetite nanoparticles in a large pH window with di erent bases. Materials6, 5549 5567. doi: 10.3390/ma6125549 McMahon, M. T., and Bulte, J. W. (2018). Two decades of dendrimers as versatile MRI agents: a tale with and without metals.Wiley Interdisciplinary Rev. Nanomed. Nanobiotechnol.10:e1496. doi: 10.1002/wnan.1496 McNamara, K., and Tofail, S. A. (2017). Nanoparticles in biomedicalapp ications. Adv. Phys.2, 54 88. doi: 10.1080/23746149.2016.1254570 Mody, V. V., Cox, A., Shah, S., Singh, A., Bevins, W., and Parihar, H. (2014). Magnetic nanoparticle drug delivery systems for targeting tumor.Appl. Nanosci.4, 385 392. doi: 10.1007/s13204-013-0216-y Mohammed, L., Gomaa, H. G., Ragab, D., and Zhu, J. (2017). Magnetic nanoparticles for environmental and biomedical applications: a review. Particuology30, 1 14. doi: 10.1016/j.partic.2016.06.001 Monsalve, A., Vicente, J., Grippin, A., and Dobson, J. (2017). Poly (lactic acid) magnetic microparticle synthesis and surface functionalization.IEEE Magn. Lett.8, 1 5. doi: 10.1109/LMAG.2017.2726505 Naghibi, S., Sani, M. A. F., and Hosseini, H. R. M. (2014). Application of the statistical Taguchi method to optimize TiO2 nanoparticles synthesis by the hydrothermal assisted sol gel technique.Ceramics Int.40, 4193 4201. doi: 10.1016/j.ceramint.2013.08.077 Nassar, M. Y., Ahmed, I. S., Mohamed, T. Y., and Khatab, M. (2016). A controlled, template-free, and hydrothermal synthesis route to sphere-like aFe 2 O 3 nanostructures for textile dye removal.RSC Adv.6, 20001 20013. doi: 10.1039/C5RA26112K Njagi, E. C., Huang, H., Sta ord, L., Genuino, H., Galindo, H. M., Collins, J. B., et al. (2010). Biosynthesis of iron and silver nanoparticles at room temperature using aqueous sorghum bran extracts.Langmuir27, 264 271. doi: 10.1021/la103190n Pang, Y. L., Lim, S., Ong, H. C., and Chong, W. T. (2016). Research progress on iron oxide-based magnetic materials: synthesis techniques and photocatalytic applications.Ceramics Int.42, 9 34. doi: 10.1016/j.ceramint.2015.08.144\nFrontiers in Materials | www.frontiersin.org 14 July 2019 | Volume 6 | Article 179\nPatsula, V., KosinovÆ, L., Lovri,c, M., Ferhatovic Hamzic, L.,Rabyk, M., Konefal, R., et al. (2016). Superparamagnetic Fe3O4 nanoparticles: synthesis by thermal decomposition of iron (III) glucuronate and application in magnetic resonance imaging.ACS Appl. Mater. Interfaces8, 7238 7247. doi: 10.1021/acsami.5b12720 Rai, M., Maliszewska, I., Ingle, A., Gupta, I., and Yadav, A. (2015). Diversity of microbes in synthesis of metal nanoparticles: progress and limitations, n BioNanoparticles: Biosynthesis and Sustainable Biotechnological Implications, ed O. V. Singh (Chichester: Wiley), 1 30. doi: 10.1002/9781118677629.ch1 Rajiv, P., Bavadharani, B., Kumar, M. N., and Vanathi, P. (2017). Synthesis and characterization of biogenic iron oxide nanoparticles using greenchemistry approach and evaluating their biological activities.Biocatalysis Agricult. Biotechnol.12, 45 49. doi: 10.1016/j.bcab.2017.08.015 Riaz, S., Naseem, S., and Han, X. (2015). Citric acid coated iron oxide nanoparticles Structural and magnetic properties, in2015 IEEE International Magnetics Conference (INTERMAG)(IEEE). doi: 10.1109/INTMAG.2015.7157349 Sakellari, D., Brintakis, K., Kostopoulou, A., Myrovali, E., Simeonidis, K., Lappas, A., et al. (2016). Ferrimagnetic nanocrystal assemblies as vers tile magnetic particle hyperthermia mediators.Mater. Sci. Eng. C58, 187 193. doi: 10.1016/j.msec.2015.08.023 Sathya, K., Saravanathamizhan, R., and Baskar, G. (2017). Ultrasound assisted phytosynthesis of iron oxide nanoparticle.Ultrasonics Sonochem.39, 446 451. doi: 10.1016/j.ultsonch.2017.05.017 Schneider, M. G. M., and Lassalle, V. L. (2017). Magnetic iron oxide nanoparticles as novel and e cient tools for atherosclerosis diagnosis.B omed. Pharmacother. 93, 1098 1115. doi: 10.1016/j.biopha.2017.07.012 Seeli, D. S., and Prabaharan, M. (2017). Guar gum oleate-graft-poly(methacrylic acid) hydrogel as a colon-speci c controlled drug delivery carrier.Carbohydrate Polymers158, 51 57. doi: 10.1016/j.carbpol.2016.11.092 Shah, M., Fawcett, D., Sharma, S., Tripathy, S., and Poinern, G. (2015). Green synthesis of metallic nanoparticles via biological entities.Materials8, 7278 7308. doi: 10.3390/ma8115377 Smith, T. W., and Wychick, D. (1980). Colloidal iron dispersions prepared via the polymer-catalyzed decomposition of iron pentacarbonyl.J. Phys. Chem.84, 1621 1629. doi: 10.1021/j100449a037 Sood, A., Arora, V., Shah, J., Kotnala, R. K., and Jain, T. K. (2017). Multifunctional gold coated iron oxide core-shell nanoparticles stabilized using thiolated sodium alginate for biomedical applications.Mater. Sci. Eng. C80, 274 281. doi: 10.1016/j.msec.2017.05.079 Sun, Z., Worden, M., Thliveris, J. A., Hombach-Klonisch, S., Klonisch, T., van Lierop, J., et al. (2016). Biodistribution of negatively charged iron oxide nanoparticles (IONPs) in mice and enhanced brain delivery using lysophosphatidic acid (LPA).Nanomed. Nanotechnol. Biol. Med.12, 1775 1784. doi: 10.1016/j.nano.2016.04.008 Surowiec, Z., Budzynski, M., Durak, K., and Czernel, G. (2017). Synthesis and characterization of iron oxide magnetic nanoparticles.Nukleonika62, 73 77. doi: 10.1515/nuka-2017-0009 Taboada, E., Rodríguez, E., Roig, A., Oró, J., Roch, A., and Muller, R. N. (2007). Relaxometric and magnetic characterization of ultrasmall ironoxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging.Langmuir23, 4583- 4588. doi: 10.1021/la063415s Tadic, M., Panjan, M., Damnjanovic, V., and Milosevic, I. (2014). Magnetic properties of hematite (a-Fe2O3) nanoparticles prepared by hydrothermal synthesis method.Appl. Surface Sci.320, 183 187. doi: 10.1016/j.apsusc.2014.08.193 TombÆcz, E., Turcu, R., Socoliuc, V., and VØkÆs, L. (2015). Magnetic iron oxide nanoparticles: recent trends in design and synthesis of magnetoresponsive nanosystems.Biochem. Biophys. Res. Commun.468, 442 453. doi: 10.1016/j.bbrc.2015.08.030 Veiseh, O., Gunn, J. W., and Zhang, M. (2010). Design and fabric tion of magnetic nanoparticles for targeted drug delivery and imaging.Adv. Drug Delivery Rev. 62, 284 304. doi: 10.1016/j.addr.2009.11.002 Wang, Y., Chen, J., Yang, B., Qiao, H., Gao, L., Su, T., et al. (2016). In vivo MR and uorescence dual-modality imaging of atherosclerosis characte istics in mice using pro lin-1 targeted magnetic nanoparticles.Theranostics6, 272. doi: 10.7150/thno.13350 Watt, J., Bleier, G. C., Austin, M. J., Ivanov, S. A., and Huber,D. L. (2017). Non-volatile iron carbonyls as versatile precursors for the synthesis of ironcontaining nanoparticles.Nanoscale9, 6632 6637. doi: 10.1039/C7NR01028A Wee, S.-B., Oh, H.-C., Kim, T.-G., An, G.-S., and Choi, S.-C. (2017). Role of N-methyl-2-pyrrolidone for preparation of Fe3O4@ SiO2 controlled the shell thickness.J. Nanoparticle Res.19:143. doi: 10.1007/s11051-017-3813-y Williams, M. J., SÆnchez, E., Aluri, E. R., Douglas, F. J., MacLaren,D. A. Collins, O. M., et al. (2016). Microwave-assisted synthesis of highly crystalline, multifunctional iron oxide nanocomposites for imaging applications. RSC Adv. 6, 83520 83528. doi: 10.1039/C6RA11819D Xiao, Y.-D., Paudel, R., Liu, J., Ma, C., Zhang, Z.-S., and Zhou, S.-K. (2016). MRI contrast agents: classi cation and application.I t. J. Mol. Med.38, 1319 1326. doi: 10.3892/ijmm.2016.2744 Xu, X., Yadav, N. N., Song, X., McMahon, M. T., Jerschow, A., Van Zijl, P. C., et al. (2016). Screening CEST contrast agents using ultrafast CEST imaging.J. Magn. Resonance265, 224 229. doi: 10.1016/j.jmr.2016.02.015 Yang, K. M., Cho, H. I., Choi, H. J., and Piao, Y. (2014). Synthesis of water well-dispersed PEGylated iron oxide nanoparticles for MR/optical lymph node imaging.J. Mater. Chem. B2, 3355 3364. doi: 10.1039/C4TB0 0084F Yang, X. C., Shang, Y. L., Li, Y. H., Zhai, J., Foster, N. R., Li, Y. X., et al. (2014). Synthesis of monodisperse Iron oxide nanoparticles without surfactants.J. Nanomater.2014:231. doi: 10.1155/2014/740856 Yelenich, O. V., Solopan, S. O., Kolodiazhnyi, T. V., Greneche, J.M., and Belous, A. G. (2015). Synthesis of iron oxide nanoparticles by di erent methods and study of their properties, inSolid State Phenomena, Vol. 230(Zurich: Trans Tech Publications), 108 113. doi: 10.4028/www.scienti c.net/SSP.230.108 Yildirim, A., Chattaraj, R., Blum, N. T., and Goodwin, A. P. (2016).Understanding acoustic cavitation initiation by porous nanoparticles: toward nanoscale agents for ultrasound imaging and therapy.Chem. Mater.28, 5962 5972. doi: 10.1021/acs.chemmater.6b02634 Yoo, S. P., Pineda, F., Barrett, J. C., Poon, C., Tirrell, M., and Chung, E. J. (2016). Gadolinium-functionalized peptide amphiphile micelles for multimodal imaging of atherosclerotic lesions.ACS Omega1, 996 1003. doi: 10.1021/acsomega.6b00210 Yu, S. M., Laromaine, A., and Roig, A. (2014). Enhanced stability of superparamagnetic iron oxide nanoparticles in biological media using a pH adjusted-BSA adsorption protocol.J. Nanopart. Res.16:2484. doi: 10.1007/s11051-014-2484-1 Yu, W., Sun, T. W., Ding, Z., Qi, C., Zhao, H., Chen, F., et al. (2017). Copperdoped mesoporous hydroxyapatite microspheres synthesized by a microwavehydrothermal method using creatine phosphate as an organic phosphorus source: application in drug delivery and enhanced bone regeneration. J. Mater. Chem. B5, 1039 1052. doi: 10.1039/C6TB02747D Zhao, H., Liu, R., Zhang, Q., and Wang, Q. (2016). E ect of surfactant amount on the morphology and magnetic properties of monodisperse ZnFe2O4 nanoparticles. Mater. Res. Bull.75, 172 177. doi: 10.1016/j.materresbull.2015.11.052 Zheng, Y., Hunting, D. J., Ayotte, P., and Sanche, L. (2008). Radiosensitization of DNA by gold nanoparticles irradiated with high-energy electrons.Radiat. Res. 169, 19 27. doi: 10.1667/RR1080.1 Con ict of Interest Statement: The authors declare that the research was conducted in the absence of any commercial or nancial relationship that could be construed as a potential con ict of interest. Copyright ' 2019 Gul, Khan, Rehman, Khan and Khan. This is an open-access article distributed under the terms of the Creative CommonsAttribution License (CC BY). The use, distribution or reproduction in other forums ispermitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.\nFrontiers in Materials | www.frontiersin.org 15 July 2019 | Volume 6 | Article 179"
    } ],
    "references" : [ {
      "title" : "Theranostic applicat",
      "author" : [ "N. Ahmed", "H. Fessi", "A. Elaissari" ],
      "venue" : null,
      "citeRegEx" : "Ahmed et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Ahmed et al\\.",
      "year" : 2012
    }, {
      "title" : "Synthesis, characterization, applications, and challeng",
      "author" : [ "A. ain" ],
      "venue" : null,
      "citeRegEx" : "ain,? \\Q2016\\E",
      "shortCiteRegEx" : "ain",
      "year" : 2016
    }, {
      "title" : "Impact of particle elasticit",
      "author" : [ "S. Mitragotri" ],
      "venue" : null,
      "citeRegEx" : "Anselmo and Mitragotri,? \\Q2017\\E",
      "shortCiteRegEx" : "Anselmo and Mitragotri",
      "year" : 2017
    }, {
      "title" : "Next revolution",
      "author" : [ "L. Bissonnette", "M.G. Bergeron" ],
      "venue" : "d romatic compounds.Biodegradation14,",
      "citeRegEx" : "Bissonnette and Bergeron,? \\Q2006\\E",
      "shortCiteRegEx" : "Bissonnette and Bergeron",
      "year" : 2006
    }, {
      "title" : "Role of biomechanical forces in the natural history",
      "author" : [ "M.R. nnett" ],
      "venue" : null,
      "citeRegEx" : "nnett,? \\Q2016\\E",
      "shortCiteRegEx" : "nnett",
      "year" : 2016
    }, {
      "title" : "Magnetic nanoparticles: particle science, i",
      "author" : [ "T.M. Buzug" ],
      "venue" : null,
      "citeRegEx" : "Buzug,? \\Q2010\\E",
      "shortCiteRegEx" : "Buzug",
      "year" : 2010
    }, {
      "title" : "Mechanistic aspec",
      "author" : [ "R. Deshmukh", "M. Niederberger" ],
      "venue" : null,
      "citeRegEx" : "Deshmukh and Niederberger,? \\Q2017\\E",
      "shortCiteRegEx" : "Deshmukh and Niederberger",
      "year" : 2017
    }, {
      "title" : "Polyol synthesis",
      "author" : [ "H. Dong", "Y.C. Chen", "C. Feldmann" ],
      "venue" : null,
      "citeRegEx" : "Dong et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Dong et al\\.",
      "year" : 2015
    }, {
      "title" : "Economically attractive route for the prepa",
      "author" : [ "S.H. Masunaga", "Jardim", "R. F" ],
      "venue" : null,
      "citeRegEx" : "Masunaga et al\\.,? \\Q2017\\E",
      "shortCiteRegEx" : "Masunaga et al\\.",
      "year" : 2017
    }, {
      "title" : "Immune system and cardiovascular",
      "author" : [ "I. FernÆndez-Ruiz" ],
      "venue" : null,
      "citeRegEx" : "FernÆndez.Ruiz,? \\Q2016\\E",
      "shortCiteRegEx" : "FernÆndez.Ruiz",
      "year" : 2016
    }, {
      "title" : "Exploring deformable particles in vascular-tar",
      "author" : [ "R Adili" ],
      "venue" : null,
      "citeRegEx" : "Adili,? \\Q2017\\E",
      "shortCiteRegEx" : "Adili",
      "year" : 2017
    }, {
      "title" : "Magnetic nanoparticle",
      "author" : [ "G. N", "M Jafelicci Jœnior" ],
      "venue" : null,
      "citeRegEx" : "N. and Jœnior,? \\Q2015\\E",
      "shortCiteRegEx" : "N. and Jœnior",
      "year" : 2015
    }, {
      "title" : "Hydrothermal synt",
      "author" : [ "Y. Guo", "Z. Wang", "H. Shao", "X. Jiang" ],
      "venue" : null,
      "citeRegEx" : "Guo et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Guo et al\\.",
      "year" : 2013
    }, {
      "title" : "Polyol synthesis, functionalisation, and bi",
      "author" : [ "S in-Colin" ],
      "venue" : null,
      "citeRegEx" : "in.Colin,? \\Q2016\\E",
      "shortCiteRegEx" : "in.Colin",
      "year" : 2016
    }, {
      "title" : "Tuning sizes, morphologies, and magnetic properties",
      "author" : [ ],
      "venue" : null,
      "citeRegEx" : "F,? \\Q2017\\E",
      "shortCiteRegEx" : "F",
      "year" : 2017
    }, {
      "title" : "2017). Gold nanoparticles",
      "author" : [ "S. Her", "D.A. Ja ray", "C. Allen" ],
      "venue" : null,
      "citeRegEx" : "Her et al\\.,? \\Q2017\\E",
      "shortCiteRegEx" : "Her et al\\.",
      "year" : 2017
    }, {
      "title" : "Monodisperse magnetic nanopart",
      "author" : [ "D. Ho", "X. Sun", "S. Sun" ],
      "venue" : null,
      "citeRegEx" : "Ho et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Ho et al\\.",
      "year" : 2011
    }, {
      "title" : "icles for theranostic applications",
      "author" : [ "K. Hola", "Z. Markova", "G. Zoppellaro", "J. Tucek", "R. Zboril" ],
      "venue" : "Accounts Chem",
      "citeRegEx" : "Hola et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Hola et al\\.",
      "year" : 2015
    }, {
      "title" : "Synthesis of phase-pure and monodispers",
      "author" : [ "R. Hufschmid", "H. Arami", "R.M. Ferguson", "M. Gonzales", "E. Teeman", "Brush", "L. N" ],
      "venue" : null,
      "citeRegEx" : "Hufschmid et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Hufschmid et al\\.",
      "year" : 2015
    }, {
      "title" : "A novel single step synthesis and surfac",
      "author" : [ "R. FL: CRC Press. Kandasamy" ],
      "venue" : null,
      "citeRegEx" : "Kandasamy,? \\Q2017\\E",
      "shortCiteRegEx" : "Kandasamy",
      "year" : 2017
    }, {
      "title" : "Evaluation of PEG-coated iron oxide",
      "author" : [ "P.W. ill", "Conolly", "S. M" ],
      "venue" : null,
      "citeRegEx" : "ill et al\\.,? \\Q2017\\E",
      "shortCiteRegEx" : "ill et al\\.",
      "year" : 2017
    }, {
      "title" : "The greener synthesis of nanoparticles",
      "author" : [ "V.M.J. Ørez" ],
      "venue" : null,
      "citeRegEx" : "Ørez,? \\Q2013\\E",
      "shortCiteRegEx" : "Ørez",
      "year" : 2013
    }, {
      "title" : "Magnetic nanopart",
      "author" : [ "T. Kobayashi", "A. Ito", "H. Honda" ],
      "venue" : null,
      "citeRegEx" : "Kobayashi et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Kobayashi et al\\.",
      "year" : 2016
    }, {
      "title" : "Magnetic nanopa",
      "author" : [ "E.L. Salabas", "F. Schüth" ],
      "venue" : null,
      "citeRegEx" : "Lu et al\\.,? \\Q2007\\E",
      "shortCiteRegEx" : "Lu et al\\.",
      "year" : 2007
    }, {
      "title" : "Biosynthesis of stable iron oxide",
      "author" : [ "Yaminsky", "I. V" ],
      "venue" : null,
      "citeRegEx" : "Yaminsky and V,? \\Q2014\\E",
      "shortCiteRegEx" : "Yaminsky and V",
      "year" : 2014
    }, {
      "title" : "Tumor sti ening, a key determinant",
      "author" : [ "C. chiol", "S. Natkhunarajah" ],
      "venue" : null,
      "citeRegEx" : "chiol and Natkhunarajah,? \\Q2017\\E",
      "shortCiteRegEx" : "chiol and Natkhunarajah",
      "year" : 2017
    }, {
      "title" : "Green synthesis of iron oxide nanopa",
      "author" : [ "M.E.S. de Vicente" ],
      "venue" : null,
      "citeRegEx" : "Vicente,? \\Q2016\\E",
      "shortCiteRegEx" : "Vicente",
      "year" : 2016
    }, {
      "title" : "Room temperature co-preci",
      "author" : [ "M. Mascolo", "Y. Pei", "T. Ring" ],
      "venue" : "ndus rarak DC.Mater",
      "citeRegEx" : "Mascolo et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Mascolo et al\\.",
      "year" : 2013
    }, {
      "title" : "Two decades of dendrimer",
      "author" : [ "M.T. McMahon", "J.W. Bulte" ],
      "venue" : "rent bases",
      "citeRegEx" : "McMahon and Bulte,? \\Q2018\\E",
      "shortCiteRegEx" : "McMahon and Bulte",
      "year" : 2018
    }, {
      "title" : "Nanoparticles in biomedical",
      "author" : [ "K. McNamara", "S.A. Tofail" ],
      "venue" : null,
      "citeRegEx" : "McNamara and Tofail,? \\Q2017\\E",
      "shortCiteRegEx" : "McNamara and Tofail",
      "year" : 2017
    }, {
      "title" : "Magnetic nanoparticle drug delivery systems for targeting tumor",
      "author" : [ "H. ar" ],
      "venue" : null,
      "citeRegEx" : "ar,? \\Q2014\\E",
      "shortCiteRegEx" : "ar",
      "year" : 2014
    }, {
      "title" : "Biosynthesis of iron and silver nanoparticles at room tempera",
      "author" : [ "llins", "J. B" ],
      "venue" : null,
      "citeRegEx" : "llins and B,? \\Q2010\\E",
      "shortCiteRegEx" : "llins and B",
      "year" : 2010
    }, {
      "title" : "Citric acid coated iron oxide nanoparticlesStructural and magnetic properties,",
      "author" : [ "S. Riaz", "S. Naseem", "X. Han" ],
      "venue" : "IEEE International Magnetics Conference (INTERMAG)",
      "citeRegEx" : "Riaz et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Riaz et al\\.",
      "year" : 2015
    }, {
      "title" : "Ferrimagnetic nanocrystal assemblies",
      "author" : [ "A Lappas" ],
      "venue" : null,
      "citeRegEx" : "Lappas,? \\Q2016\\E",
      "shortCiteRegEx" : "Lappas",
      "year" : 2016
    }, {
      "title" : "Magnetic iron ox",
      "author" : [ "M.G.M. Schneider", "V.L. Lassalle" ],
      "venue" : null,
      "citeRegEx" : "Schneider and Lassalle,? \\Q2017\\E",
      "shortCiteRegEx" : "Schneider and Lassalle",
      "year" : 2017
    }, {
      "title" : "Guar gum oleate-graft-poly",
      "author" : [ "D.S. Seeli", "M. Prabaharan" ],
      "venue" : null,
      "citeRegEx" : "Seeli and Prabaharan,? \\Q2017\\E",
      "shortCiteRegEx" : "Seeli and Prabaharan",
      "year" : 2017
    }, {
      "title" : "Carbohydrate Polymers158, 5157",
      "author" : [ "M. Shah", "D. Fawcett", "S. Sharma", "S. Tripathy", "G. Poinern" ],
      "venue" : null,
      "citeRegEx" : "Shah et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Shah et al\\.",
      "year" : 2016
    }, {
      "title" : "Colloidal iron dispersions pre",
      "author" : [ "T.W. Smith", "D. Wychick" ],
      "venue" : null,
      "citeRegEx" : "Smith and Wychick,? \\Q1980\\E",
      "shortCiteRegEx" : "Smith and Wychick",
      "year" : 1980
    }, {
      "title" : "Biodistribution of negatively char",
      "author" : [ "J van Lierop" ],
      "venue" : null,
      "citeRegEx" : "Lierop,? \\Q2016\\E",
      "shortCiteRegEx" : "Lierop",
      "year" : 2016
    }, {
      "title" : "Design and fabri",
      "author" : [ "O. Veiseh", "J.W. Gunn", "M. Zhang" ],
      "venue" : null,
      "citeRegEx" : "Veiseh et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "Veiseh et al\\.",
      "year" : 2010
    }, {
      "title" : "Microwave-assisted synthesis of h",
      "author" : [ "Collins", "O. M" ],
      "venue" : null,
      "citeRegEx" : "Collins and M,? \\Q2016\\E",
      "shortCiteRegEx" : "Collins and M",
      "year" : 2016
    }, {
      "title" : "Synthesis of monodisperse Iron oxide nanoparticles without surfa",
      "author" : [ ],
      "venue" : null,
      "citeRegEx" : "X,? \\Q2014\\E",
      "shortCiteRegEx" : "X",
      "year" : 2014
    }, {
      "title" : "Synthesis of iron oxide nanoparticles by di erent methods and study of their properties,",
      "author" : [ "A.G. Belous" ],
      "venue" : "inSolid State Phenomena, Vol. 230(Zurich: Trans Tech Publications),",
      "citeRegEx" : "M. and Belous,? \\Q2015\\E",
      "shortCiteRegEx" : "M. and Belous",
      "year" : 2015
    }, {
      "title" : "Gadolinium-functionalized peptide amphiphile micelles",
      "author" : [ "J. E" ],
      "venue" : null,
      "citeRegEx" : "E.,? \\Q2016\\E",
      "shortCiteRegEx" : "E.",
      "year" : 2016
    }, {
      "title" : "Enhanced stabilit",
      "author" : [ "S.M. Yu", "A. Laromaine", "A. Roig" ],
      "venue" : null,
      "citeRegEx" : "Yu et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Yu et al\\.",
      "year" : 2014
    }, {
      "title" : "E ect of surfactant amount on the morphology and magnetic properties of monodisperse ZnFe",
      "author" : [ "H. Zhao", "R. Liu", "Q. Zhang", "Q. Wang" ],
      "venue" : null,
      "citeRegEx" : "Zhao et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Zhao et al\\.",
      "year" : 2016
    }, {
      "title" : "hip that could be construed as a potential con ict of interest",
      "author" : [ "Gul", "Khan", "Rehman" ],
      "venue" : null,
      "citeRegEx" : "Gul et al\\.,? \\Q2019\\E",
      "shortCiteRegEx" : "Gul et al\\.",
      "year" : 2019
    } ],
    "referenceMentions" : [ {
      "referenceID" : 23,
      "context" : "form surface complexes by competing mechanisms ( Lu et al., 2007).",
      "startOffset" : 47,
      "endOffset" : 65
    }, {
      "referenceID" : 14,
      "context" : "(D) wrapping conformation of the polymer(E) coatings with opposite charges(F) amphiphilic polymers [adapted and modi ed fromBarrow et al. (2015)and Habibi",
      "startOffset" : 75,
      "endOffset" : 145
    }, {
      "referenceID" : 7,
      "context" : "FIGURE 5 | Polyol route for the synthesis of nanoparticles [adapted an d modi ed from Dong et al. (2015)].",
      "startOffset" : 86,
      "endOffset" : 105
    }, {
      "referenceID" : 12,
      "context" : "Precursors’ concentration controls the size and size distribution; however, the duration of the reaction had a ec t d the average particle size more signi cantly; monodisperse particles were obtained at shorter reaction times ( Guo et al., 2013).",
      "startOffset" : 226,
      "endOffset" : 245
    }, {
      "referenceID" : 30,
      "context" : "numerous applications in clinical research [adapted and mo di ed from Makarov et al. (2014)and Baranwal et al.",
      "startOffset" : 38,
      "endOffset" : 92
    }, {
      "referenceID" : 30,
      "context" : "numerous applications in clinical research [adapted and mo di ed from Makarov et al. (2014)and Baranwal et al. (2016) ].",
      "startOffset" : 38,
      "endOffset" : 118
    }, {
      "referenceID" : 22,
      "context" : "Gold nanoparticles displayed exc ellent biocompatibility, enhanced stability and increased accumu lation in computed tomography tumor imaging ( Kobayashi et al., 2016).",
      "startOffset" : 142,
      "endOffset" : 167
    } ],
    "year" : 0,
    "abstractText" : "Substances at nanoscale, commonly known as nanomaterials , have always grabbed the attention of researchers for hundreds of years. Among th ese different types of nanomaterials, magnetic nanomaterials have been the focus of considerable attention during the last two decades as evidenced by an unprecedentedincrease in the number of research papers focusing these materials. Iron oxide mag netic nanoparticles have occupied a vital position in imaging phenomena; as drug vehi cles, controlled/sustained release phenomena and hyperthermia; atherosclerosis diag nosis; prostate cancer. In fact, these are wonderful theranostic agents with some under clinical trials for human use. In this review, we have attempted to highlight the advan ces taking place in the eld of magnetic nanoparticles as theranostic agents. Exte nsive progress has been made in the two most important parameters, namely, control over the size and shape which decide the importance of iron oxide magnetic nanopart icles by developing suitable procedures like precipitation, co-precipitation, thermal decomposition, hydrothermal synthesis, microemulsion synthesis and plant mediated syn thesis. After using a suitable synthetic route, workers encounter the most daunting task l inked with the materials at nanoscale i.e., the protection against corrosion. Only p roperly protected iron oxide magnetic nanoparticles can be further connected to differe nt functional systems to make building blocks for application in catalysis, biology and medicines. Finally, theranostics which is a combined application of imaging and drug deliveryhas been discussed. With all the potential uses, toxicity of the of iron oxide mag netic nanoparticles has been discussed.",
    "creator" : null
  }
}